TY - JOUR
T1 - A Portuguese expert panel position paper on the management of heart failure with preserved ejection fraction - part I
T2 - pathophysiology, diagnosis and treatment
AU - Silva-Cardoso, José
AU - Moreira, Emília
AU - Melo, Rachel Tavares de
AU - Moraes-Sarmento, Pedro
AU - Cardim, Nuno
AU - Oliveira, Mário
AU - Gavina, Cristina
AU - Moura, Brenda
AU - Araújo, Inês
AU - Santos, Paulo
AU - Peres, Marisa
AU - Fonseca, Cândida
AU - Ferreira, João Pedro
AU - Marques, Irene
AU - Andrade, Aurora
AU - Baptista, Rui
AU - Brito, Dulce
AU - Cernadas, Rui
AU - Santos, Jonathan dos
AU - Leite-Moreira, Adelino
AU - Gonçalves, Lino
AU - Ferreira, Jorge
AU - Aguiar, Carlos
AU - Fonseca, Manuela
AU - Fontes-Carvalho, Ricardo
AU - Franco, Fátima
AU - Lourenço, Carolina
AU - Martins, Elisabete
AU - Pereira, Hélder
AU - Santos, Mário
AU - Pimenta, Joana
N1 - Publisher Copyright:
© 2025
PY - 2025/4
Y1 - 2025/4
N2 - Heart failure (HF) with preserved ejection fraction (HFpEF) affects more than 50% of HF patients worldwide, and more than 70% of HF patients aged over 65. This is a complex syndrome with a clinically heterogeneous presentation and a multifactorial pathophysiology, both of which make its diagnosis and treatment challenging. A Portuguese HF expert panel convened to address HFpEF pathophysiology and therapy, as well as appropriate management within the Portuguese context. This initiative resulted in two position papers that examine the most recently published literature in the field. The present Part I includes a review of the HFpEF literature covering pathophysiology, clinical presentation, diagnosis and treatment, including pharmacological and non-pharmacological strategies. Part II, the second paper, addresses the development of a holistic and integrated HFPEF clinical care system within the Portuguese context that is capable of reducing morbidity and mortality and improving patients’ functional capacity and quality of life.
AB - Heart failure (HF) with preserved ejection fraction (HFpEF) affects more than 50% of HF patients worldwide, and more than 70% of HF patients aged over 65. This is a complex syndrome with a clinically heterogeneous presentation and a multifactorial pathophysiology, both of which make its diagnosis and treatment challenging. A Portuguese HF expert panel convened to address HFpEF pathophysiology and therapy, as well as appropriate management within the Portuguese context. This initiative resulted in two position papers that examine the most recently published literature in the field. The present Part I includes a review of the HFpEF literature covering pathophysiology, clinical presentation, diagnosis and treatment, including pharmacological and non-pharmacological strategies. Part II, the second paper, addresses the development of a holistic and integrated HFPEF clinical care system within the Portuguese context that is capable of reducing morbidity and mortality and improving patients’ functional capacity and quality of life.
KW - Diagnosis
KW - Heart failure
KW - Heart failure with preserved ejection fraction
KW - HFpEF
KW - Pathophysiology
KW - Treatment
KW - Insuficiência cardíaca
KW - Insuficiência cardíaca com fração de ejeção preservada
KW - ICEp
KW - Fisiopatologia
KW - Diagnóstico
KW - Tratamento
UR - http://www.scopus.com/inward/record.url?scp=105001569508&partnerID=8YFLogxK
U2 - 10.1016/j.repc.2024.11.011
DO - 10.1016/j.repc.2024.11.011
M3 - Review article
C2 - 39978763
AN - SCOPUS:105001569508
SN - 0870-2551
VL - 44
SP - 233
EP - 243
JO - Revista Portuguesa de Cardiologia
JF - Revista Portuguesa de Cardiologia
IS - 4
ER -